←
HealthAsia10,767 posts
HealthAsia avatar

HealthAsia

@farhadali

Public health strategist decoding urban health & NCDs. Asia lens, global lessons. Nutrition, policy & climate, evidence first.

◷ Joined November 2009▧ 2,476 Photos and videos
HealthAsia avatar
HealthAsia@farhadali·Sep 10

This is me, and this is what I've spent my career fighting for. Cleaner air. Better food. Healthier cities. A planet we can actually live on. None of it happens alone. If any of this resonates, join me — let's amplify the impact together. 🌏

Post attachment
HealthAsia avatar
HealthAsia@farhadali·9h

I've been building HealthAsia for the past 1 year and have one belief: better public health conversations lead to better public policy. I want to spotlight accounts doing similar meaningful work in public health, urban health, nutrition, climate or governance. What are you researching, creating, questioning or changing right now? Introduce yourself, share your idea. I'll pick every account to feature. Let's help good ideas travel further.

HealthAsia avatar
HealthAsia@farhadali·9h

Narrow streets cool a city by ~4.2°C. Green walls by ~3°C. Trees, permeable pavements and cool roofs add more. These are proven, low-tech fixes — not future tech. So what stops our cities from adapting?"

Post attachment
HealthAsia avatar
HealthAsia@farhadali·14h

4/ Japan’s heart-cell therapy, approved the same day, costs ¥53.2m. If these work, every health system faces the same choice. Would yours pay $350,000 per patient?

HealthAsia avatar
HealthAsia@farhadali·14h

3/ Japan made a deliberate bet: approve on thin evidence, then give the company seven years to prove it in more patients. Faster access, more uncertainty.

HealthAsia avatar
HealthAsia@farhadali·14h

2/ She’s already back at work, per Sumitomo. But that’s recovery from surgery. Transplanted cells can take a year or more to start working, so whether it helps her won’t be known for a while.

HealthAsia avatar
HealthAsia@farhadali·14h

A woman in her 50s in Kyoto is the first patient to receive a stem-cell therapy for Parkinson’s that a government has actually approved. The evidence behind it: 7 patients. The price: ¥55.3m (~$350,000). Who pays: Japan’s public health insurance.

Post attachment
HealthAsia avatar
HealthAsia@farhadali·18h

70% of Filipino adults support mandatory food warnings. In a 2025 mock-up test of 3-in-1 coffee, only 11% said they’d buy it as usual with a black octagon. Stated intent, not sales. Bills remain in committee. Congress: what is holding them up?

Post attachment
HealthAsia avatar
HealthAsia@farhadali·20h

Dengue is no longer just a seasonal challenge for cities. Bangladesh has recorded 1,537 hospitalisations in a single day and 507 deaths. The season is lasting longer than usual. Warmer conditions, urbanisation and gaps in vector control make preparedness even more urgent. Are cities adapting fast enough? #Bangladesh

Post attachment
HealthAsia avatar
HealthAsia@farhadali·20h

Delhi just lifted its toughest pollution curbs — but the air is still 'poor'. AQI fell to 204, so Stage III emergency measures are off. Stages I and II stay, and 'very poor' air is forecast again this week. Relief, not recovery. How long before the next spike?

Post attachment
HealthAsia avatar
HealthAsia@farhadali·Nov 17

Recent outages affecting Microsoft, US air traffic control and major banks are reminders of how dependent everyday life has become on complex technology. These weren't AI failures. But as AI becomes more autonomous, the stakes of getting governance wrong grow. What safety checks should be mandatory before deployment at scale?

Post attachment
HealthAsia avatar
HealthAsia@farhadali·Nov 17

Nepal's recent Himalayan disaster killed more than 1,400 people and left thousands missing. Yet Nepal contributes just 0.1% of global emissions. COP31's draft proposes $120 bn annually for adaptation, against $305 bn needed. Climate justice means more than promises. Will finance reach countries like Nepal as grants, and in time?

Post attachment